Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment
2010 · BMC Gastroenterology · 10 citations
https://doi.org/10.1186/1471-230x-10-38
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
532
Citations
9
h-index
9
i10-index
Hiroaki Taniai is an academic researcher from Harasanshin Hospital. The author has contributed to research in topics: Hepatitis C virus research & Hepatitis B Virus Studies & Liver Disease Diagnosis and Treatment. The author has an h-index of 9, co-authored 20 publications.
Click to start Chat